February 2021
NACDD is collaborating with the CDC’s Clinical Standardization Programs, the Endocrine Society, and the Partnership for the Accurate Testing of Hormones to improve patient care and public health by promoting the use of accurate and reliable laboratory measurements for chronic disease biomarkers in healthcare and research. The project uses a multi-pronged approach, including working to increase the number of standardized laboratory assays available; educating physicians, payers, patients, policymakers, and laboratories to increase adoption of certified, standardized laboratory tests (e.g. CDC Hormone Standardization Programs); and fostering partnerships and collaboration to address data needs and advance the quality of laboratory tests.
Recent project highlights include:
- Development of a recorded webinar for NACDD Members, Accurate and Reliable Chronic Disease Biomarker Measurements to Support Public Health Actions, that provides an overview of the importance of standardized biomarker assays for public health;
- Launch of a four-part series of online modules designed to educate endocrinology fellows and endocrinologists on accurate hormone testing, available free of charge as part of the Endocrine Society’s Fellows Training Series and public catalogue; and
- Formation of a partnership with Avalon Healthcare Systems, a laboratory benefits manager serving multiple insurance companies, to promote the use of standardized assays and conduct a pilot study about the impact of policy language and education on the use of standardized testosterone tests in patient care.
View more information about this work. For all other questions, contact Laura DeStiger.